See more : Hortifrut S.A. (HF.SN) Income Statement Analysis – Financial Results
Complete financial analysis of Xcorporeal, Inc. (XCRP) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Xcorporeal, Inc., a leading company in the Medical – Specialties industry within the Healthcare sector.
- MMI Globale Aktier Akk. – Harding Loevner (MMIGAA.CO) Income Statement Analysis – Financial Results
- Rojana Industrial Park Public Company Limited (RJIFF) Income Statement Analysis – Financial Results
- Pro-Pac Packaging Limited (PPG.AX) Income Statement Analysis – Financial Results
- GARODIA CHEMICALS LTD. (GARODCH.BO) Income Statement Analysis – Financial Results
- Obayashi Corporation (OBYCF) Income Statement Analysis – Financial Results
Xcorporeal, Inc. (XCRP)
Industry: Medical - Specialties
Sector: Healthcare
About Xcorporeal, Inc.
Xcorporeal, Inc. is in the process of liquidation and dissolution, pursuant to the plan adopted by board of directors of the company on February 4, 2010. The company has formed the liquidating trust, Xcorporeal, Inc. Liquidating Trust, and transferred all of its assets to the trust for the purpose of completing the liquidation and dissolution of the company. Previously, it operated as a medical device company, which was engaged in the development of an extra-corporeal platform technology to be used in devices to replace the function of various human organs. Xcorporeal, Inc. was founded in 2001 and is based in Lake Forest, California.
| Metric | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 460.99K | 4.40M | 1.61M | 5.33M |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 8.31K | 200.00K | 78.43K | 304.44K |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 452.68K | 4.20M | 1.53M | 5.02M |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 98.20% | 95.45% | 95.14% | 94.28% |
| Research & Development | 20.91M | 7.14M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 112.99K | 500.00K | 161.01K | 3.34M |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 9.00M | 11.08M | 99.19K | 177.63K | 107.35K | 296.26K | 2.26M | 735.38K | 2.92M | 7.00M | 3.06M | 5.94M |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 31.89M | 18.26M | 99.19K | 177.63K | 107.35K | 296.26K | 2.26M | 735.38K | 3.95M | 9.10M | 4.86M | 12.20M |
| Cost & Expenses | 31.89M | 18.26M | 99.19K | 177.63K | 107.35K | 296.26K | 2.26M | 735.38K | 3.96M | 9.30M | 4.94M | 12.51M |
| Interest Income | 323.25K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 465.18K | 494.34K | 1.23M | 125.43K | 128.96K | 9.26K | 9.13K | 100.00K | 128.93K | 253.56K |
| Depreciation & Amortization | 104.66K | 32.09K | 250.29K | 160.86K | 60.00K | -1.58M | 3.55M | -1.45M | 917.49K | 1.60M | 1.27M | 942.17K |
| EBITDA | -22.88M | -17.04M | 5.79M | -16.77K | -3.00M | -1.87M | 1.29M | -2.19M | 2.10M | -1.10M | -1.85M | -5.90M |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 454.75% | -25.00% | -114.72% | -110.81% |
| Operating Income | -31.89M | -18.26M | -99.19K | -177.63K | -107.35K | -296.26K | -2.26M | -735.38K | -3.50M | -4.90M | -3.32M | -7.18M |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -758.94% | -111.36% | -205.92% | -134.80% |
| Total Other Income/Expenses | 7.04M | 1.18M | 5.89M | 0.00 | -2.90M | 1.58M | -3.55M | 1.45M | -4.68M | -2.20M | -200.58K | -4.19M |
| Income Before Tax | -22.99M | -17.07M | 5.79M | 0.00 | -3.01M | 1.28M | -5.80M | 719.12K | -8.18M | -7.10M | -3.52M | -7.52M |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -1,773.61% | -161.36% | -218.35% | -141.11% |
| Income Tax Expense | 1.63K | 1.60K | -5.42M | 494.34K | 4.12M | 70.08K | 1.26M | 1.81M | 4.63M | 1.80M | 200.58K | 335.73K |
| Net Income | -22.99M | -17.07M | 5.33M | -671.97K | -4.23M | 1.21M | -7.06M | -1.09M | -8.13M | -6.70M | -3.52M | -7.52M |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -1,762.59% | -152.27% | -218.35% | -141.11% |
| EPS | -1.57 | -1.20 | 4.43 | -0.56 | -3.57 | 1.12 | -7.18 | -1.23 | -98.73 | -13.49 | -11.74 | -30.67 |
| EPS Diluted | -1.57 | -1.20 | 4.43 | -0.56 | -3.57 | 1.12 | -7.18 | -1.23 | -98.73 | -13.49 | -11.74 | -30.67 |
| Weighted Avg Shares Out | 14.60M | 14.21M | 1.20M | 1.20M | 1.18M | 1.07M | 983.56K | 888.12K | 82.30K | 496.58K | 300.04K | 245.02K |
| Weighted Avg Shares Out (Dil) | 14.60M | 14.21M | 1.20M | 1.20M | 1.18M | 1.07M | 983.56K | 888.12K | 82.30K | 496.58K | 300.04K | 245.02K |
Source: https://incomestatements.info
Category: Stock Reports